The saponin D39 blocks dissociation of non‐muscular myosin heavy chain IIA from TNF receptor 2, suppressing tissue factor expression and venous thrombosis
Male
Venous Thrombosis
0301 basic medicine
Glycogen Synthase Kinase 3 beta
Myosin Heavy Chains
Tumor Necrosis Factor-alpha
Transcription Factor RelA
Saponins
Thromboplastin
Mice, Inbred C57BL
Molecular Docking Simulation
03 medical and health sciences
HEK293 Cells
Fibrinolytic Agents
Human Umbilical Vein Endothelial Cells
Animals
Humans
Receptors, Tumor Necrosis Factor, Type II
Proto-Oncogene Proteins c-akt
Cells, Cultured
DOI:
10.1111/bph.13885
Publication Date:
2017-05-26T09:02:44Z
AUTHORS (10)
ABSTRACT
Background and Purpose Non‐muscular myosin heavy chain IIA (NMMHC IIA) plays a key role in tissue factor expression venous thrombosis. Natural products might inhibit thrombosis through effects on NMMHC IIA. Here, we have shown that natural saponin, D39, from Liriope muscari exerted anti‐thrombotic activity vivo , by targeting Experimental Approach Expression of endothelial cells were analysed vitro Western blot simplified chromogenic assays. Interactions between D39 assessed serial affinity chromatography molecular docking analysis. D39‐dependent interactions TNF receptor 2 (TNFR2) measured immunofluorescence, co‐immunoprecipitation proximity ligation Anti‐thrombotic was evaluated with model inferior vena cava injury mice. Key Results inhibited procoagulant activities HUVECs decreased thrombus weight cava‐ligated mice dose‐dependently. Serial analysis suggested bound to In HEK293T cells, evoked overexpression. This effect blocked knockdown HUVECs. dissociation TNFR2, which subsequently modulated the Akt/GSK3β–NF‐κB signalling pathways. Conclusions Implications formation modulating Akt/GSK3β NF‐κB pathways We identified new product targeted IIA, as potential treatment for thrombotic disorders other vasculopathies.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (52)
CITATIONS (58)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....